Lippia nodiflora has been traditionally used for treatment of knee joint pain. Hitherto, no studies have been reported on the effective use of L. nodiflora against hyperuricemia, gout or other metabolic disorders. In this present study, L. nodiflora was examined for its ability to lower uric acid levels using an in vitro xanthine oxidase inhibitory assay. The whole plant methanolic extract was subjected to bioactivity-guided fractionation to yield 4 fractions (F1-F4). F3 displayed the highest potency and was further purified by column chromatography to afford two phenylethanoid glycosides, arenarioside (1) and verbascoside (2), and three flavonoids, 6-hydroxyluteolin (3), 6-hydroxyluteolin-7-O-glycoside (4), and nodifloretin (5). These compounds inhibited xanthine oxidase activity, with IC 50 values between 7.52 ± 0.01 and 130.00 ± 2.25 μM, of which 3 was the most potent. In contrast, allopurinol, serving as a positive control, was 0.22 ± 0.00 μM. Thus, L. nodiflora, and its chemical constituents are worthy of further studies as potential anti-hyperuricemic agents.
Hyperuricemia is a disease exhibiting an abnormally high level of uric acid in blood due mainly to hyperactivity of xanthine oxidase (XOD), low excretion of uric acid or both [1] . By reducing the high plasma uric acid level, the conditions of hyperuricemia, gout and other related metabolic disorders may be prevented, treated or controlled [2] . Currently, allopurinol, a potent XOD inhibitor, is commonly used for treating patients with gout and hyperuricemia by reducing serum uric acid production [3, 4] . However, various adverse effects have been associated with allopurinol therapy that have limited its usage, including gastrointestinal distress, hypersensitivity reactions, and skin rashes [5] .
Many phytochemicals have been investigated as preventive and healing candidates against hyperuricemia and gout [6] . In particular, plant flavonoids, alkaloids, essential oils, phenolic acids, tannins, iridoid glycosides, coumarins, and lignans have been reported as potential anti-hyperuricemic agents [7, 8] . Lippia nodiflora, a fast growing creeping perennial herb belonging to the family Verbenaceae [9] , also known as phyla nodiflora or locally as "frog fruit", is widely distributed throughout the more temperate to subtropical regions [10] . L. nodiflora has been reported to contain nodifloridin A, nodifloridin B [11, 12] , nodifloretin, β-sitosterol glycoside and stigmasterol glycoside [12, 13] . Two flavone glycosides, 6-hydroxyluteolin-7-O-apioside and luteolin-7-Oglucoside, and three flavones, 6-hydroxyluteolin, nepetin, and batatifolin, have been isolated from the flowers of L. nodiflora [14] . Twelve flavone sulfates, hispidulin-7-sulfate, hispidulin-7,4'disulfate, jaceosidin-7,4'-disulfate, nepetin-3',4'-disulfate, nodifloretin-6,7-disulfate, 6-hydroxyluteolin-6,7-disulfate, nodifloretin-7sulfate, 6-hydroxyluteolin-6-sulfate, 6-hydroxyluteolin-7-sulfate, jaceosidin-7-sulfate, nepetin-7-sulfate, and hispidulin-4'-sulfate, along with hispidulin, and jaceosidin have also been identified [15, 16] . Two new flavone glycosides, lippiflorin A and lippiflorin B, together with batalilfolin were isolated from the ethanol extract of L. nodiflora [17] . Two phenylpropanoid compounds, acteoside (verbascoside) and 2'-O-acetylechinacoside, and flavones, demethoxycentaureidin have also been identified from the alcoholic extracts [18] . Halleridone and hallerone as their acetyl derivatives were extracted from the leaves of L. nodiflora [19] . A new triterpenoid, lippiacin, and a new steroid, 4',5'-dimethoxybenzoloxystigmasterol, along with the known stigmasterol and β-sitosterol have been isolated from the methanolic extract of the aerial parts of L. nodiflora [20, 21] . Recently, 5-hydroxy-3',4',7trimethoxy flavones have been isolated from the aerial parts of L. nodiflora [22] .
Traditionally, L. nodiflora has been used for the treatment of knee joint pain, lithiasis, fever, asthma, diarrhea, gonorrhea, ulcers, bronchitis, heart disease, diabetes, and as a diuretic [23] [24] [25] . It has been reported to be effective against a variety of ailments due to the anti-oxidant [23, 26, 27] , anti-microbial [28] , anti-tumor [29] , antiinflammatory [30] , anti-hepatitis [31] , anti-bacteria [32] , antimelanogenesis [33] , anti-hypertensive [34] , anti-urolithiasis [35] and anti-nociceptive [36] activities. However, the antihyperuricemic effect of L. nodiflora has not been investigated and the phytochemicals involved have not been reported. The present preliminary study evaluated the potential uric acid-lowering effect of the methanolic extract, the fractions and the isolated phytochemicals of L. nodiflora using the in vitro XOD inhibitory assay.
A bioactivity-guided fractionation of the methanolic extract of L. nodiflora was performed involving testing the fractions and isolated phytochemicals for uric acid-lowering activity using the in vitro XOD inhibitory assay. The methanolic extract upon evaporation to dryness and resin chromatography afforded 4 fractions (F1-F4). Further purification of the most potent fraction, F3, yielded two phenylethanoid glycosides, arenarioside (1) and verbascoside (2), and three flavonoids, 6-hydroxyluteolin (3), 6-hydroxyluteolin-7-Oglycoside (4), and nodifloretin (5) (Figure 1 ). These compounds were identified by comparison of their NMR, IR, and UV spectroscopic and mass spectrometric data with those in the literature [37] [38] [39] [40] [41] [42] . The NMR data (CD 3 Arenarioside (1) was first isolated from Orobanche arenaria [37] . This compound from Marrubium vulgare was reported to exhibit inhibitory activity against cyclooxygenase [43] , and from Brandisia hancei, it was found to possess xanthine oxidase inhibitory activity [44] .
Verbascoside (2) (synonym of acteoside) is commonly found in the genus Lippia and was isolated from L. dulcis Trevir, L. multiflora Moldenke, L. triphylla (L. Hér) Kuntze [45] [46] [47] [48] [49] [50] and L. nodiflora [15, 51] . It was also found in Scrophularia ningpoensis and exhibited a hypouricemic effect in potassium oxonate-pretreated hyperuricemic mice [52] . It was further identified in Cistanche deserticola and reported to possess free radical scavenging activities on the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical and xanthine/xanthine oxidase (XOD) generated superoxide anion radical (O 2-) [53] . 6-Hydroxyluteolin (3) and its 7-O-glycoside (4) have been identified from Chrysanthemum morifolium Ramar and screened as selective inhibitors of xanthine oxidase using ultrafiltration LC-MS combined with enzyme channel blocking (ECB) [54] . Compound 3 was also previously isolated from L. nodiflora [14, 51] , whereas 4 has been reported in the plant for the first time.
Previously, nodifloretin (5) was isolated from L. nodiflora [12, 13] , and is indigenous to the plant. Compound 5 has been tested for antiinflammatory and growth inhibitory effects against human leukemia HL-60 cells [42] . However, the XOD inhibitory activity of 5 has not been reported.
The highest in vitro XOD inhibitory activity of the methanolic extract fractions of L. nodiflora was observed for F3 (IC 50 39.3 ± 1.9 μg/mL), followed by F4 (IC 50 168.6 ± 6.1 μg/mL) and F2 (IC 50 198.0 ± 0.8 μg/mL). The IC 50 value of F1 was not able to be determined due to its extremely low potency for XOD inhibitory activity (IC 50 > 800.0 μg/mL).
The XOD inhibitory activities of the five isolated compounds were examined. Although 1-5 are known phytochemicals, their in vitro uric acid-lowering effects due to xanthine oxidase inhibition are reported here for the first time. Compound 3 was the most potent, followed by 5, 4, 2, and 1. The IC 50 value of 7.5 ± 0.01 μM for 3 was 34 fold less potent than that of allopurinol (IC 50 0.22 ± 0.00 μM). The IC 50 values of 5, 4, 2, and 1 were 13.9 ± 0.05, 30.4 ± 0.07, 115.1 ± 0.3, and 130.0 ± 2.2 μM, respectively.
From the results, the flavonoid compounds showed higher XOD inhibitory activity than the phenylethanoid glycosides. The three flavonoid compounds isolated are structurally similar, with 4 having an additional sugar group at C7, whereas 5 has an additional methoxy group at C3' compared with 3. By comparing their in vitro XOD inhibitory results, the presence of a methoxy group in 5 or a sugar group in 4 displayed no enhancement of XOD inhibition in vitro, since 3 showed the most potency.
We concluded that the flavonoid compounds were responsible for the XOD inhibitory effect exhibited by L. nodiflora. Compounds 3, 4 and 5 are promising candidates for the development of uric acidlowering agents due to their XOD inhibitory effects. Further in vivo studies are ongoing and the mechanisms of action involved are being investigated.
Experimental

Chemicals and reagents:
Xanthine oxidase enzyme from buttermilk was purchased from Merck (Darmstadt, Germany), xanthine, dimethyl sulfoxide (DMSO), and allopurinol from Sigma (USA), sodium dihydrogen phosphate anhydrous from R & M Chemicals (Essex, UK), and disodium hydrogen phosphate anhydrous from Merck (Darmstadt, Germany). The deionized water was prepared using a Maxima ultra pure water purifier system (Elgastat; Bucks, England). Resin of styrene and divinylbenzene (Diaion HP 20) was purchased from Mitsubishi (Tokyo, Japan). The solvents used for column chromatography were of analytical grade and were purchased from Merck (Darmstadt, Germany). 1 H-and 13 C-NMR spectra were obtained using a Bruker Avance III 500 MHz spectrometer (Bruker Biospin AG; Fallanden, Switzerland). Nicolet Fourier Transform Infrared Nexus (Thermo Nicolet Corp.; Madison, WI, USA) was used for obtaining the IR spectra. ESI-MS of 1 and 2 were obtained using a Waters Xevo G2 Q-TOF mass spectrometer (Waters Corporation, Milford, MA, USA), whereas 3, 4 and 5 were measured using a Bruker impact HD Q-TOF mass spectrometer (Bruker Daltonics GmbH, Bremen, Germany). Column chromatography was performed using Sephadex TM LH-20 (No. 17-0090-02, GE Healthcare, Sweden). Evaporation was performed using a rotary evaporator (Buchi R-114; Switzerland). Semipreparative HPLC isolation was performed using a Zorbax column (ODS 9.4 mm × 25 cm). Thin layer chromatography (TLC) was conducted on pre-coated aluminum plates containing Kieselgel plate 60-F 254 (0.2 mm thickness, No. 5544, Merck) from Merck (Darmstadt, Germany), with 10% sulfuric acid in ethanol (EtOH) (v/v) as spray. UV spectra and absorbance of the enzymatic reaction were measured using Perkin Elmer Lambda 45 spectrophotometer (Perkin Elmer Instrument; Norwalk, CT, USA).
General experimental procedures:
Plant material: L. nodiflora was collected in Seremban, Negeri Sembilan, in August 2012. A voucher specimen was deposited at the Herbarium of the University of Science Malaysia.
Extraction, isolation, and identification:
The air-dried powdered whole plant of L. nodiflora (7 kg) was extracted repeatedly with methanol (MeOH) at room temperature. The total methanolic solution upon evaporation in vacuo yielded 1.05 kg (15% w/w) of dark green residue, which was subsequently chromatographed on a Diaion HP-20 column with a H 2 0-MeOH (1:0-0:1) gradient to afford 4 fractions (F1-4). F3 was concentrated under vacuum to In vitro xanthine oxidase inhibitory studies of Lippia nodiflora Natural Product Communications Vol. 10 (6) 2015 947
give 157.5 g of residue. This was purified using a semi-preparative HPLC technique with a H 2 0-MeOH (65 %: 35 %) solvent system to afford 1 (26.6 mg) and 2 (29.7 mg) . F3 was also subjected to repeated Sephadex LH-20 CC eluting with MeOH to yield 3 (135.1 mg), 4 (145.2 mg), and 5 (125.9 mg).
Determination of XOD inhibitory activity:
The inhibitory effect against XOD was determined spectrophotometrically as described by Noro et al. and Vikneswaran et al. [55] [56] with modification. The reaction mixture consisted of 100 µL of test solution, 290 µL of phosphate buffer (50 mM, pH 7.8), and 10 µL of enzyme solution (0.4 U/mL). The test samples were dissolved in DMSO and diluted with phosphate buffer (50 mM, pH 7.8) to give a final concentration of 1% in the reaction mixture. After pre-incubation of the reaction mixture at 37 o C for 10 min, the reaction was initiated by adding 200 µL of substrate solution (0.15 mM). The reaction mixture was then incubated at 37 o C for 10 min. The reaction was terminated by adding 100 µL of 1 N HCl, and the absorbance of the reaction mixture was measured at 292 nm. A blank was prepared in the same way, but the enzyme solution was added to the reaction mixture after the addition of 1 N HCl. All determinations were performed in triplicate. The XOD inhibitory activity was expressed as the percentage inhibition (%) of XOD = (1 ˗ b/a) × 100, where "a" is the activity of the enzyme without the sample and "b" is the activity of the enzyme with the sample.
